Serum Oxidized LDL Levels in Type 2 Diabetic Patients with Retinopathy in Mthatha Region of the Eastern Cape Province of South Africa
Table 3
Clinical characteristics in different groups.
Variables
Groups
Control (nondiabetic) ()
Diabetic without retinopathy ()
DR ()
value
FPG (mmol/L)
4.9 (5.2–4.6)
8.1 (10.5–6.3)
9.6 (13.1–6.5)
<0.0005
HbA1c (%)
6.0 (6.1–5.8)
8.1 (10.2–6.8)
9.0 (11.1–8.0)
<0.0005
Total cholesterol (mmol/L)
4.80 (5.37–3.87)
4.50 (5.05–3.67)
4.55 (5.37–3.83)
0.438
LDL cholesterol (mmol/L)
2.75 ± 0.88
2.51 ± 0.96
2.65 ± 1.01
0.490
HDL cholesterol (mmol/L)
1.35 (1.52–1.10)
1.11 (1.40–1.0)
1.18 (1.36–0.91)
0.007
Triglyceride (mmol/L)
1.10 (1.52–0.90)
1.30 (2.0–1.0)
1.50 (2.54–1.11)
0.004
Total antioxidant (mM)
0.60 (0.80–0.44)
0.47 (0.61–0.37)
0.34 (0.45–0.23)
<0.0005
TBARS (μM)
3.38 (4.62–2.32)
4.33 (6.0–3.3)
5.08 (6.12–4.0)
<0.0005
Serum oxidized LDL (U/L)
81.76 ± 31.74
97.52 ± 40.67
146.9 ± 56.67
<0.0005
Data is shown as median and IQR (interquartile range) and mean ± SD. The median and mean difference is significant at , , and level. DR: diabetic retinopathy.